Virtual Reality (VR) has emerged as a new safe and efficient tool for the rehabilitation of many childhood and adulthood illnesses. VR-based therapies have the potential to improve both motor and functional skills in a wide range of age groups through cortical reorganization and the activation of various neuronal connections. Recently, the potential for using serious VR-based games that combine perceptual learning and dichoptic stimulation has been explored for the rehabilitation of ophthalmological and neurological disorders. In ophthalmology, several clinical studies have demonstrated the ability to use VR training to enhance stereopsis, contrast sensitivity, and visual acuity. The use of VR technology provides a significant advantage in training each eye individually without requiring occlusion or penalty. In neurological disorders, the majority of patients undergo recurrent episodes (relapses) of neurological impairment, however, in a few cases (60–80%), the illness progresses over time and becomes chronic, consequential in cumulated motor disability and cognitive deficits. Current research on memory restoration has been spurred by theories about brain plasticity and findings concerning the nervous system's capacity to reconstruct cellular synapses as a result of interaction with enriched environments. Therefore, the use of VR training can play an important role in the improvement of cognitive function and motor disability. Although there are several reviews in the community employing relevant Artificial Intelligence in healthcare, VR has not yet been thoroughly examined in this regard. In this systematic review, we examine the key ideas of VR-based training for prevention and control measurements in ocular diseases such as Myopia, Amblyopia, Presbyopia, and Age-related Macular Degeneration (AMD), and neurological disorders such as Alzheimer, Multiple Sclerosis (MS) Epilepsy and Autism spectrum disorder. This review highlights the fundamentals of VR technologies regarding their clinical research in healthcare. Moreover, these findings will raise community awareness of using VR training and help researchers to learn new techniques to prevent and cure different diseases. We further discuss the current challenges of using VR devices, as well as the future prospects of human training.
Angle closure glaucoma leads to fluid deposition in eye, and intraocular pressure occurs that damage the optic nerve, causes blindness and vision loss. Anterior chamber (AC) evaluation is imperative for determining the risk of angle‐closure. Previously, techniques were dependent on either Pentacam–Scheimpflug that interprets poor visual information, anterior segment optical coherence tomography is injurious to intercede opaque optical structures. Therefore, in this paper, an experimental protocol is designed for detailed disease analysis based on IBM SPSS statistics via ultrasound biomicroscopy which is superior in evaluating deep structures; first, the affected parameter for AC is analysed, and afterwards the direction that needs laser surgery is explored. Experiments are conducted on large‐scale clinical studies from an affiliated hospital in Shanghai, China. The dataset comprised 600 AC images in five directions of 60 subjects. The mean with standard deviation for anterior open distance is 0.15879±$\pm$0.096779 mm, 0.15863±$\pm$0.081435 mm, and anterior chamber angle is 18.749±$\pm$08.0315∘$^{\circ }$, 18.741±$\pm$08.3889∘$^{\circ }$ for left and right eye respectively. It is found that anterior chamber angle in the downside of the AC is wider than the upside. However, this decision is partly based on the narrowest part of the angle to widen the depth of the direction and eliminate pupil block.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.